Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity
- PMID: 8934229
- DOI: 10.1089/hum.1996.7.17-2157
Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity
Abstract
Five different single-chain antibody fragments (scFv) against human cell-surface antigens were displayed on murine ecotropic retroviral vectors by fusing them to the Moloney SU envelope glycoprotein. The spacing between the scFv and the SU glycoprotein was varied by fusing the scFv to residue +7 or to residue +1 of Moloney SU and by inserting linker sequences of different lengths between the domains. All of the chimeric envelopes were efficiently incorporated into vector particles and could bind to human cells through their displayed antibody fragments, but did not infect them. The spacing between the scFvs and the SU glycoproteins had no significant effect on the efficiency of envelope expression or viral incorporation and did not affect the binding properties of the chimeric envelopes, nor did it influence the efficiency of targeted gene delivery to human cells by scFv-displaying vectors. However, on murine fibroblasts the infectivity of vectors incorporating the chimeric envelopes was strongly influenced by the length of the interdomain spacer. The titers were very low when the single-chain antibodies were fused through a tripeptide linker to SU residue +7 and were greatly enhanced (up to 10(5)-fold) when they were fused to SU residue +1 through a heptapeptide linker. These results point to the importance of steric interactions between the domains of chimeric envelope glycoproteins and may have implications for retroviral vector design for human gene therapy.
Similar articles
-
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.J Virol. 1996 Mar;70(3):2059-64. doi: 10.1128/JVI.70.3.2059-2064.1996. J Virol. 1996. PMID: 8627737 Free PMC article.
-
Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.Gene Ther. 1996 Apr;3(4):334-42. Gene Ther. 1996. PMID: 8732165
-
Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.Hum Gene Ther. 1998 Mar 20;9(5):737-46. doi: 10.1089/hum.1998.9.5-737. Hum Gene Ther. 1998. PMID: 9551621
-
Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin.Hum Gene Ther. 1999 Jun 10;10(9):1533-44. doi: 10.1089/10430349950017860. Hum Gene Ther. 1999. PMID: 10395378
-
Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.Virology. 1997 Jul 21;234(1):51-61. doi: 10.1006/viro.1997.8628. Virology. 1997. PMID: 9234946
Cited by
-
Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types.Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9867-72. doi: 10.1073/pnas.96.17.9867. Proc Natl Acad Sci U S A. 1999. PMID: 10449786 Free PMC article.
-
Antibody-directed targeting of retroviral vectors via cell surface antigens.J Virol. 2001 Sep;75(17):8016-20. doi: 10.1128/jvi.75.17.8016-8020.2001. J Virol. 2001. PMID: 11483746 Free PMC article.
-
Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cells.Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9860-5. doi: 10.1073/pnas.1414754112. Epub 2015 Jul 27. Proc Natl Acad Sci U S A. 2015. PMID: 26216971 Free PMC article.
-
Viral vectors for gene transfer: a review of their use in the treatment of human diseases.Drugs. 2000 Aug;60(2):249-71. doi: 10.2165/00003495-200060020-00002. Drugs. 2000. PMID: 10983732 Review.
-
Cell type-specific delivery by modular envelope design.Nat Commun. 2023 Aug 23;14(1):5141. doi: 10.1038/s41467-023-40788-8. Nat Commun. 2023. PMID: 37612276 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources